Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Haese

Showing results (191-200 of 214) with videos related to

Pageof 22
Sort By:
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 13, 2019
The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancerFranziska Büscheck, Maciej Zub, Asmus Heumann, et al.
Molecular Oncology|November 19, 2019
Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancerDoris Höflmayer, Amélie Steinhoff, Claudia Hube-Magg, et al.
Neoplasia (New York, N.Y.)|August 6, 2019
Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical ProstatectomySarah Minner, Dominik Hager, Stefan Steurer, et al.
Cancer Biology & Medicine|September 14, 2019
Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of <i>PTEN</i> deleted prostate cancersAndreas M Luebke, Ali Attarchi-Tehrani, Jan Meiners, et al.
Oncotarget|April 19, 2017
Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancerChristoph Burdelski, Laura Borcherding, Martina Kluth, et al.
The Journal of Pathology|January 19, 2023
Automated Ki-67 labeling index assessment in prostate cancer using artificial intelligence and multiplex fluorescence immunohistochemistryNiclas C Blessin, Cheng Yang, Tim Mandelkow, et al.
Oncotarget|January 7, 2020
Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusionStefan Steurer, Lara Schwemmer, Claudia Hube-Magg, et al.
Disease Markers|May 8, 2020
Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate CancerAndreas Marx, Andreas M Luebke, Till S Clauditz, et al.
Neoplasia (New York, N.Y.)|June 24, 2025
Prognostic role of high MTAP expression is reversed by the ERG status in prostate cancer treated by radical prostatectomyNatalia Gorbokon, Seyma Büyücek, Henning Plage, et al.
Molecular Medicine (Cambridge, Mass.)|March 8, 2020
Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusionChristoph Fraune, Luisa Harms, Franziska Büscheck, et al.
Pageof 22

Showing results (191-200 of 214) with videos related to

Sort By:
Pageof 22
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 13, 2019
The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancerFranziska Büscheck, Maciej Zub, Asmus Heumann, et al.
Molecular Oncology|November 19, 2019
Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancerDoris Höflmayer, Amélie Steinhoff, Claudia Hube-Magg, et al.
Neoplasia (New York, N.Y.)|August 6, 2019
Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical ProstatectomySarah Minner, Dominik Hager, Stefan Steurer, et al.
Cancer Biology & Medicine|September 14, 2019
Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of <i>PTEN</i> deleted prostate cancersAndreas M Luebke, Ali Attarchi-Tehrani, Jan Meiners, et al.
Oncotarget|April 19, 2017
Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancerChristoph Burdelski, Laura Borcherding, Martina Kluth, et al.
The Journal of Pathology|January 19, 2023
Automated Ki-67 labeling index assessment in prostate cancer using artificial intelligence and multiplex fluorescence immunohistochemistryNiclas C Blessin, Cheng Yang, Tim Mandelkow, et al.
Oncotarget|January 7, 2020
Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusionStefan Steurer, Lara Schwemmer, Claudia Hube-Magg, et al.
Disease Markers|May 8, 2020
Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate CancerAndreas Marx, Andreas M Luebke, Till S Clauditz, et al.
Neoplasia (New York, N.Y.)|June 24, 2025
Prognostic role of high MTAP expression is reversed by the ERG status in prostate cancer treated by radical prostatectomyNatalia Gorbokon, Seyma Büyücek, Henning Plage, et al.
Molecular Medicine (Cambridge, Mass.)|March 8, 2020
Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusionChristoph Fraune, Luisa Harms, Franziska Büscheck, et al.
Pageof 22